Publications

Found 55 results
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Moeller S, Lau NM, Green PHR, Hellberg D, Higgins JJ, Rajadhyaksha AM, Alaedini A.  2013.  Lack of association between autism and anti-GM1 ganglioside antibody.. Neurology. 81(18):1640-1.
Akuffo AA, Alontaga AY, Metcalf R, Beatty MS, Becker A, McDaniel JM, Hesterberg RS, Goodheart WE, Gunawan S, Ayaz M et al..  2018.  Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.. J Biol Chem. 293(16):6187-6200.
Ambrose C, Lowman H, Rajadhyaksha A, Blasquez V, Bina M.  1990.  Location of nucleosomes in simian virus 40 chromatin.. J Mol Biol. 214(4):875-84.
Ambrose C, Rajadhyaksha A, Lowman H, Bina M.  1989.  Locations of nucleosomes on the regulatory region of simian virus 40 chromatin.. J Mol Biol. 210(2):255-63.
Eaton ME, Macías W, Youngs RM, Rajadhyaksha A, Dudman JT, Konradi C.  2004.  L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons.. Brain Res Mol Brain Res. 131(1-2):65-72.
Rajadhyaksha A, Barczak A, Macías W, Leveque JC, Lewis SE, Konradi C.  1999.  L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons.. J Neurosci. 19(15):6348-59.
Kabir ZD, Lee AS, Rajadhyaksha AM.  2016.  L-type Ca(2+) channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes.. J Physiol. 594(20):5823-5837.
Rajadhyaksha A, Husson I, Satpute SS, Küppenbender KD, Ren JQ, Guerriero RM, Standaert DG, Kosofsky BE.  2004.  L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment.. J Neurosci. 24(34):7464-76.
Addy NA, Nunes EJ, Hughley SM, Small KM, Baracz SJ, Haight JL, Rajadhyaksha AM.  2018.  The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.. Neuropsychopharmacology.